This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Company Filing History:
1 out of 834,307 Years Active: 2001
Title: Amy K Evans: Innovator in Anti-Infective Research
Introduction
Amy K Evans is a notable inventor based in West Linn, OR (US). She has made significant contributions to the field of anti-infective research, particularly through her innovative work on protease function.
Latest Patents
Amy K Evans holds a patent for her invention titled "DegP periplasmic protease a new anti-infective target and an in vitro assay for DegP protease function." This invention focuses on the DegP (HtrA) protease, which is essential for the removal of misfolded and aggregated proteins in the periplasm. The patent describes an assay for inhibitors of DegP activity, which involves mixing a suspected inhibitor with DegP and a suitable substrate, such as PapA, to detect changes in DegP activity. This research is crucial as DegP has been shown to be essential for virulence in several Gram-negative pathogens.
Career Highlights
Throughout her career, Amy has demonstrated a strong commitment to advancing scientific knowledge and developing innovative solutions to combat infections. Her work has led to a deeper understanding of the DegP protease and its role in bacterial virulence.
Collaborations
Amy has collaborated with notable colleagues, including Hal C Jones and Scott J Hultgren, to further her research and enhance the impact of her inventions.
Conclusion
Amy K Evans is a pioneering inventor whose work on the DegP protease has the potential to lead to new anti-infective therapies. Her contributions to the field are invaluable and highlight the importance of innovation in addressing public health challenges.